Final Program as PDF documents: General Program | Friday | Saturday | Sunday

• For Macintosh (.sit, 440K)
• For Windows (.zip, 520 K)

• New Treatment Options for AECB
  Martinez Fernando, USA
• Why Aren't Clinical Failures Following In Vitro Resistance Patterns?
  Bishai William, USA
• Improving Treatment Options for Sinusitis Patients
  Anon Jack, USA
• Can RTIs Be Treated by a Single Dose of an Antibiotic?
  Arguedas Adriano, COSTA RICA

• Human Papillomavirus: Rationale for the Introduction of Human Papillomavirus Vaccines in the Prevention of Cervical Cancer
  Munoz Nubia, FRANCE
• Human Papillomavirus: Investigational Prophylactic Human Papillomavirus Vaccines as Tools for Cervical Cancer Control
  Lazcano Ponce Eduardo Cesar, MEXICO
• Herpes Zoster : Epidemiology and Burden of Disease
  Johnson Robert, UNITED KINGDOM
• Herpes Zoster: Progress Toward Developing a Vaccine to Prevent Herpes Zoster
  Levin Myron, USA

• HCV Transmission in Prisons: How Much, How Do We Stop It?
  Goldberg David, UNITED KINGDOM
• MRSA: Changing from an Institutionally Acquired to a Community Acquired Pathogen
  Christiansen Keryn, AUSTRALIA
• Nosocomially Acquired Tuberculosis: Recognizing and Preventing Transmission
  Rangel-Fraustro Sigfrido, MEXICO
• The Role of Institutions in HIV Spread in Low-resource Communities
  Mehtar Shaheen, SOUTH AFRICA

Diseases of the Developing World
Friday, March 5, 2004, 10:30 to 12:30hrs, Room 4

• Starting Point: Ancient Diseases, Current Problems and Future Discoveries
  Hentschel Chris, SWITZERLAND
• Charting a New Course in Tuberculosis Drug Development
  Duncan Ken, UNITED KINGDOM
• Malaria on the Map
  Gomez de las Heras Federico, SPAIN
• The road Less Travelled: Anti-Leishmaniasis Therapy
  Sundar Shyam, INDIA
• Conclusions and the Road Ahead: Public-Private Partnerships
  Hentschel Chris, SWITZERLAND

• Use of Genomics and Proteomics to Develop Better Diagnostic Tools for Infectious Diseases
  Gismondo Maria Rita, ITALY
• The Bacterial Genome as a Plan for the Development of New Antibiotics
  Normark Staffan, SWEDEN
• Using the Bacterial Genome to Study Pathogenesis
  Rappuoli Rino, ITALY
• Use of Genomic Information to Develop Novel Ways of Preventing Complications of Infection
  Kasper Dennis, USA

• Prosthetic-device Infections: Trends and Controversies
  Lew Daniel, SWITZERLAND
• Therapy of Different Prosthetic-device Infections - The USA Experience
  Osmon Douglas, USA
• An Algorithm for a Systematic Approach to Prosthetic-device Infections
  Zimmerli Werner, SWITZERLAND

• Preparing for Bioterrorism: What Have We Learnt During the Past Three Years?
  Geddes Alasdair, UNITED KINGDOM
• The Rise and Stall of a Failed Policy: the US smallpox vaccination program
  del Rio Carlos, USA
• Tuberculosis in the Hospital: Implications of OSHA Withdrawing the Control Measures
  Ponce de Leon Samuel, MEXICO
• Have We Eliminated the Threat of Prion Diseases?
  Widmer Andreas, SWITZERLAND
• Lessons from the SARS Epidemic
  Wenzel Richard, USA

• Consequences of HIV/AIDS on Child Survival with Emphasis on Latin America
  speaker to be confirmed
• Managing Opportunistic Infections and HIV Complications in Low-resource Settings
  Della Negra Marinella, BRAZIL
• Strategies for Initial Therapies and Late Modifications in Children Infected with HIV
  Lepage Philippe, BELGIUM
• Enabling AIDS Orphans to Achieve Healthy Productive Adulthood: Affordable Strategies that Work
  Mendoza Aurorita, SWITZERLAND

• Immunologic Events Resulting in the Development of Bacterial Peritonitis
  Topley Nick, UNITED KINGDOM
• Etiology of Major Complications of Bacterial Peritonitis: Abscesses and Adhesions
  Tzianabos Arthur, USA
• Current Status of the Diagnosis and Treatment of Bacterial Peritonitis and iIs Complications
  Vegas Armando, VENEZUELA
• The Use of New Anti-infectives in the Treatment of Peritonitis
  Onderdonk Andrew, USA

• Influenza. A Persistent Plague for Humankind
  Nichol Kristin, USA
• Influenza in Children - Serious and Preventable
  Ruben Fred, USA
• Hepatitis A: Outbreaks and Implications for Future Vaccine Strategies
  Lopez Eduardo, ARGENTINA
• Yellow Fever 2003: Lessons Learned
  Gotuzzo Eduardo, PERU

• The Global Resurgence of Epidemic Dengue/Dengue Hemorrhagic Fever: A Challenge for the 21st Century
  Gubler Duane, USA
• Double-edged Sword: Dengue Immunology and the Pathogenesis of Disease
  Rothman Alan , USA
• Diagnosing Dengue: What Is Available and What Is Coming?
  Guzmán   María G. , CUBA
• Dengue Vaccines
  Sun Wellington, USA

• Antibiotic Resistance in Yersinia pestis
  Courvalin Patrice, FRANCE
• Fluoroquinolone Resistance in Streptococcus pneumoniae
  Seto Wing-Hong, CHINA
• Strategies to Limit Antimicrobial Resistance in the Community: What Works
  Calva Juan J., MEXICO
• Evidence-based Control of Resistant Nosocomial Pathogens
  Christiansen Keryn, AUSTRALIA

• Global Recognition and Response to Novel Public Health Threats: The SARS Story
  Stöhr Klaus, SWITZERLAND
• Epidemiology and Control of SARS in a Community: The Canadian Experience
  Poutanen Susan, CANADA
• Clinical Characteristics and Management of Patients with SARS: Lessons from Hong Kong
  Seto Wing-Hong, CHINA
• Contingency Planning for a Global Pandemic: What International Organizations Should Have Learned from SARS
  Grizzard Michael, USA

• Rotavirus: Developing a Rotavirus Vaccine: Important Immunologic Aspects
  Offit Paul, USA
• Rotavirus: Strategy for Rotavirus Vaccine Development in the Face of Safety Concerns about Intussusception
  Heaton Penny, USA
• HIV: Ongoing Development and Evaluation of a Potential HIV-1 Vaccine Using a Replication-Defective Adenoviral Vector
  Robertson Mike, USA

• Building the Rationale for Pertussis Control Worldwide and Across the Entire Lifespan
  Skowronski Danuta, CANADA
• Universal Pertussis Immunization: Ensuring Lifelong Protection
  Guiso Nicole, FRANCE
• Targeted Pertussis Immunization: Preventing Infection in Close Contacts of Newborns
  Wirsing von König Fritz, GERMANY
• Economic Burden of Pertussis and the Impact of Immunization
  Caro Jaime, USA
• Pertussis in 2004 and Beyond
  Forsyth Kevin, AUSTRALIA

• Introduction: Resistance, Surveillance and Beyond
  Alpuche Celia, MEXICO
  
  
• Surveillance Hotspots: The Highs and Lows of Regional Resistance:
  - An Introduction Klugman Keith , USA
• Surveillance Hot Spots: The Highs and Lows of Regional Resistance:
  - Asia and Far East Song Jae-Hoon, REPUBLIC OF KOREA
• Surveillance Hot Spots: The Highs and Lows of Regional Resistance:
  - Latin America Alpuche Celia, MEXICO
• Surveillance Hot Spots: The Highs and Lows of Regional Resistance:
  - Australia and New Zealand Region Turnidge John, AUSTRALIA
  
  
• Factors Behind Resistance
  Garau Javier, SPAIN
• Surveillance for the Future: Global Strategies to Control Resistance
  Klugman Keith , USA

• Malaria Vaccines
  Hill Adrian, UNITED KINGDOM
• The Role of Var Gene Expression in Pathogenesis of Malaria
  Brown Graham V., AUSTRALIA
• Consequences and Challenges of Chloroquine-resistant Malaria
  Wellems Thomas E., USA
• Impact of Drug Resistance on Malaria Treatment and Control
  Torres Jaime, VENEZUELA

• Use of Phage Lytic Enzymes for the Treatment and Control of B. anthracis and Other Pathogens
  Fischetti Vincent A., USA
• Wolbachia and Filariasis: The Bacteria behind the Worm
  Taylor Mark, UNITED KINGDOM
• Free Amoeba as Trojan Horses for Pneumonia Pathogens
  Raoult Didier, FRANCE
• Persistent bacterial infection in the immunocompetent host: Efficient generation of antigenic variants through combinatorial diversity
  Palmer Guy, USA

• Virology and Pathogenesis of Coronaviruses
  McIntosh Ken, USA
• Characterization of a Novel Coronavirus Causing Severe Acute Respiratory Syndrome
  Rota Paul, USA
• Diagnostic Tests for SARS
  LeDuc Jim, USA
• The SARS Genome and Prospects for Vaccine Development
  Rappuoli Rino, ITALY

• Hendra Virus
  McCormack Joe, AUSTRALIA
• Nipah Virus: Bats to Pigs to Men
  Chua Paul Kaw Bing, MALAYSIA
• Manifest Destiny? The Epidemiology of West Nile Virus in North America
  Petersen Lyle, USA
• Other Emerging Vector-Borne Viral Diseases
  Roehrig John, USA

• The Experience in the USA - 4 Years After Introduction of Pneumococcal Conjugate Vaccine
  Whitney Cynthia, USA
• Replacement Phenomenon and Antibiotic Resistance
  Klugman Keith , USA
• Pneumococcal Conjugate Vaccines and Antibiotic Use in Children - Are They Related?
  Dagan Ron, ISRAEL
• Expectations from Countries with High Rates of Antibiotic Resistance Beyond the USA
  Madhi Shabir, SOUTH AFRICA

• The Permeability Barrier in Gram-negative Pathogens
  Poole Keith, CANADA
• Extended-spectrum Betalactamase-mediated Resistance in Enterobacteriaceae and in Gram-negative Nonfermenters
  Gutkind Gabriel, ARGENTINA
• Zinc Carbapenemases as Emerging Resistance Determinants in Gram-negative Pathogens
  Rossolini Gian Maria, ITALY
• Antimicrobial Options for Treatment of Nosocomial Gram-negative Infections Caused by Multidrug-resistant Strains
  Bush Karen, USA

• WHO Global Program on Foodborne Diseases Surveillance
  Braam Peter, SWITZERLAND
• Non-typhoid Salmonella as a Food-borne Pathogen
  Aidara-Kane Awa, SWITZERLAND
• The Public Health Impact of Campylobacter
  Fernandez Heriberto, CHILE
• Clinical and Epidemiological Aspects of E. coli O:157:H7 in Latin America
  Cravioto Alejandro, MEXICO

• Running a Global Infectious Diseases Surveillance program: Accomplishments and Challenges for WHO
  Lazzari Stefano, SWITZERLAND
• Regional Networks for the Surveillance of Emerging Diseases and Outbreaks: Regional and International Impact
  Ungchusak Kumnuan, THAILAND
• The Role of Media and Unofficial Groups in Emerging Disease Surveillance
  Pollack Marjorie, USA
• CDC's Global Infectious Disease Activities and Challenges
  Popovic Tanja, USA

• Anthrax Vaccines: Where We Stand and Where We Are Going?
  Friedlander Arthur M., USA
• Prospects for Designing Surveillance to Identify Bioterrorism Outbreaks
  Swerdlow David, USA
• The Potential Use of Poxviruses in Bioterrorism
  Smith Geoffrey, UNITED KINGDOM

• Challenges to Diagnosing Pneumonia in Children
  Madhi Shabir, SOUTH AFRICA
• What Is the Gold Standard for the Etiological Diagnosis of Pneumonia?
  Peltola Heikki, FINLAND
• The Value of X-ray in Standardization of the Diagnosis of Pneumonia
  Cherian Thomas, SWITZERLAND
• The Use of Vaccines to Determine the Etiology of Pneumonia
  Dagan Ron, ISRAEL

• Global Eradication: What does it Need to Happen?
  Andrus Jon, USA
• Understanding Immunological Coverage for Polio Control: The Role of OPV versus IPV
  Asturias Edwin, GUATEMALA
• IPV versus OPV: Results of the Cuban Clinical Trial
  Barrios Julio, CUBA
• Maintaining Control of Polio in Latin America: The Example of Mexico
  Santos Jose Ignacio, MEXICO
• Implementing IPV in Latin American Countries
  Falleiros-Carvalho Luiza-Helena, BRAZIL

• Hantavirus an Expanding Threat in Latin America
  Vial Pablo, CHILE
• Leptospirosis in the 21st Century
  Lomar Andre, BRAZIL
• Bacteremias in Neonatal Intensive Care Units: A Deadly Presence
  Macias Hernandez Alejandro, MEXICO
• Life Threatening Infections in the Under-funded Intensive Care Unit: Views from Hell
  Rangel-Fraustro Sigfrido, MEXICO

• Are Infections with Resistant Yeasts Associated with Higher Mortality?
  Krcmery Vladimir, SLOVAKIA
• New Agents and New Strategies for the Treatment of Candida
  Cauda Roberto, ITALY
• Treating Invasive Molds: What's Available and What's Coming
  Graybill John, USA
• The Role of Molecular Assays in the Diagnosis of Systemic Invasive Fungal Infections
  Marr Kieren, USA

• Basic Molecular and Cellular Aspects of Quorum Sensing Involved in Biofilm Formation
  Iglewski Barbara, USA
• Antibiotic Tolerance in Biofilms and its Role in Persistent Infections
  Stewart Phil, USA
• Clinical Management and Therapy of Airway Biofilm Disease
  Kobayashi Hiroyuki, JAPAN
• Role of Biofilm Polysaccharides in Infection and Prospects for Immunotherapeutic Control
  Pier Gerald, USA

• Impact of HAART on Infectiousness
  Mayer Kenneth, USA
• Transmission of Resistant Virus
  Soto Ramirez Luis, MEXICO
• HIV Post-Sexual Exposure Prophylaxis
  Schechter Mauro, BRAZIL
• HIV Risk Behaviors in the Era of HAART
  Elford Jonathan, UNITED KINGDOM

• Understanding Mechanisms of Evolving Resistance in Gram-positive Bacteria
  Murray Barbara, USA
• Combination Therapy for VRSA and VRE
  Waldvogel Francis, SWITZERLAND
• New Agents for the Treatment of Multi-resistant Staphylococci and Enterococci
  Bouza Emilio, SPAIN
• Phytotherapeutics: Are They an Alternative?
  Riley Thomas, AUSTRALIA

• Bacterial Meningitis: New Trends in Epidemiology and Treatment
  Odio Carla, COSTA RICA
• Dexamethasone for Paediatric Bacterial Meningitis: Is It Beneficial in Deveolping Countries?
  Molyneux Elizabeth, MALAWI
• Oral Glycerol Versus Intravenous Dexamethasone for Childhood Bacterial Meningitis: Preliminary Results of a Clinical Trial
  Roine Irmeli, CHILE
• Developments in the Diagnosis and Management of Brain Abscess
  Brook Itzhak, USA

• Pathogenesis of Sepsis
  Opal Steven, USA
• Identifying Patients with Sepsis
  Wenzel Richard, USA
• Novel Experimental Therapies for Sepsis
  Cohen Jon, UNITED KINGDOM
• Current Therapy of Sepsis
  Maki Dennis, USA

• Treatment of Acute Pyelonephritis
  Hooton Thomas, USA
• Urinary Tract Infection in Diabetes
  Nicolle Lindsay, CANADA
• Nosocomial UTI - What can we Improve?
  Wagenlehner Florian M.E., GERMANY
• Trends in Resistance of Uropathogens: Clinical Relevance
  Krcmery Silvester, SLOVAKIA

• Emerging Versus Traditional Infections and the Traveler
  Steffen Robert, SWITZERLAND
• Travellers, Sexual Behavior, and Sexually Transmitted Infections
  Ronald Allan, CANADA
• Meningococcal Disease: Recent Emergence of W135
  Memish Ziad, SAUDI ARABIA
• Impact of Drug Resistance on Malaria Prophylaxis
  Freedman David, USA